Mgr. Ing. Taťána Malá
ANO
Twitter
AKTIVNÍ
Obsah příspěvku
Due to secondary infections during COVID-19, antimicrobial resistance (AMR) is on the rise, and some infections are increasingly untreatable. The biopharmaceutical industry continues R&D against this threat but reforms are needed to address this challenge head on.
Screenshot
Screenshot není k dispozici
Metadata
| Platforma | Twitter (social) |
| Publikováno | 21.07.2022 17:17 |
| První viděn | 12.04.2026 06:59 |
| Poslední kontrola | 25.04.2026 12:06 |
| Počet slov | 0 |
| Hlídač ID | 72da95012ded5213a3038d53885e523b |
| Original ID | 1550168126842671104 |
| Zdrojová URL | https://twitter.com/TatanaMala/status/1550168126842671104 |